Glecaprevir/Pibrentasvir Treatment in Liver or Kidney Transplant Patients With Hepatitis C Virus Infection

Reau, N; Kwo, PY; Rhee, S; Brown, RS; Agarwal, K; Angus, P; Gane, E; Kao, JH; Mantry, PS; Mutimer, D; Reddy, KR; Tran, TT; Hu, YRB; Gulati, A; Krishnan, P; Dumas, EO; Porcalla, A; Shulman, NS; Liu, W; Samanta, S; Trinh, R; Forns, X

Reau, N (reprint author), Rush Univ, Med Ctr, 1725 West Harrison St,Suite 319, Chicago, IL 60612 USA.

HEPATOLOGY, 2018; 68 (4): 1298

Abstract

Well-tolerated, ribavirin-free, pangenotypic hepatitis C virus (HCV) treatments for transplant recipients remain a high priority. Once-daily glecaprev......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索